1 Tinea Pedis Treatment Market Overview 1.1 Product Overview and Scope of Tinea Pedis Treatment 1.2 Tinea Pedis Treatment Segment by Type 1.2.1 Global Tinea Pedis Treatment Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Interdigital 1.2.3 Vesicular 1.3 Tinea Pedis Treatment Segment by Application 1.3.1 Global Tinea Pedis Treatment Sales Comparison by Application: (2021-2027) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.3.5 Drug Stores 1.3.6 Others 1.4 Global Tinea Pedis Treatment Market Size Estimates and Forecasts 1.4.1 Global Tinea Pedis Treatment Revenue 2016-2027 1.4.2 Global Tinea Pedis Treatment Sales 2016-2027 1.4.3 Tinea Pedis Treatment Market Size by Region: 2016 Versus 2021 Versus 2027 2 Tinea Pedis Treatment Market Competition by Manufacturers 2.1 Global Tinea Pedis Treatment Sales Market Share by Manufacturers (2016-2021) 2.2 Global Tinea Pedis Treatment Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Tinea Pedis Treatment Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Tinea Pedis Treatment Manufacturing Sites, Area Served, Product Type 2.5 Tinea Pedis Treatment Market Competitive Situation and Trends 2.5.1 Tinea Pedis Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Tinea Pedis Treatment Players Market Share by Revenue 2.5.3 Global Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Tinea Pedis Treatment Retrospective Market Scenario by Region 3.1 Global Tinea Pedis Treatment Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Tinea Pedis Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Tinea Pedis Treatment Market Facts & Figures by Country 3.3.1 North America Tinea Pedis Treatment Sales by Country 3.3.2 North America Tinea Pedis Treatment Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Tinea Pedis Treatment Market Facts & Figures by Country 3.4.1 Europe Tinea Pedis Treatment Sales by Country 3.4.2 Europe Tinea Pedis Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Tinea Pedis Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Tinea Pedis Treatment Sales by Region 3.5.2 Asia Pacific Tinea Pedis Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Tinea Pedis Treatment Market Facts & Figures by Country 3.6.1 Latin America Tinea Pedis Treatment Sales by Country 3.6.2 Latin America Tinea Pedis Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Tinea Pedis Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Tinea Pedis Treatment Sales by Country 3.7.2 Middle East and Africa Tinea Pedis Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Tinea Pedis Treatment Historic Market Analysis by Type 4.1 Global Tinea Pedis Treatment Sales Market Share by Type (2016-2021) 4.2 Global Tinea Pedis Treatment Revenue Market Share by Type (2016-2021) 4.3 Global Tinea Pedis Treatment Price by Type (2016-2021) 5 Global Tinea Pedis Treatment Historic Market Analysis by Application 5.1 Global Tinea Pedis Treatment Sales Market Share by Application (2016-2021) 5.2 Global Tinea Pedis Treatment Revenue Market Share by Application (2016-2021) 5.3 Global Tinea Pedis Treatment Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GSK Tinea Pedis Treatment Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 Exeltis USA 6.2.1 Exeltis USA Corporation Information 6.2.2 Exeltis USA Description and Business Overview 6.2.3 Exeltis USA Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Exeltis USA Tinea Pedis Treatment Product Portfolio 6.2.5 Exeltis USA Recent Developments/Updates 6.3 Valeant 6.3.1 Valeant Corporation Information 6.3.2 Valeant Description and Business Overview 6.3.3 Valeant Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Valeant Tinea Pedis Treatment Product Portfolio 6.3.5 Valeant Recent Developments/Updates 6.4 Incyte 6.4.1 Incyte Corporation Information 6.4.2 Incyte Description and Business Overview 6.4.3 Incyte Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Incyte Tinea Pedis Treatment Product Portfolio 6.4.5 Incyte Recent Developments/Updates 6.5 Celgene 6.5.1 Celgene Corporation Information 6.5.2 Celgene Description and Business Overview 6.5.3 Celgene Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Celgene Tinea Pedis Treatment Product Portfolio 6.5.5 Celgene Recent Developments/Updates 6.6 Hisamitsu Pharmaceutical 6.6.1 Hisamitsu Pharmaceutical Corporation Information 6.6.2 Hisamitsu Pharmaceutical Description and Business Overview 6.6.3 Hisamitsu Pharmaceutical Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Hisamitsu Pharmaceutical Tinea Pedis Treatment Product Portfolio 6.6.5 Hisamitsu Pharmaceutical Recent Developments/Updates 6.7 NovaBiotics 6.6.1 NovaBiotics Corporation Information 6.6.2 NovaBiotics Description and Business Overview 6.6.3 NovaBiotics Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 NovaBiotics Tinea Pedis Treatment Product Portfolio 6.7.5 NovaBiotics Recent Developments/Updates 6.8 Elorac 6.8.1 Elorac Corporation Information 6.8.2 Elorac Description and Business Overview 6.8.3 Elorac Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Elorac Tinea Pedis Treatment Product Portfolio 6.8.5 Elorac Recent Developments/Updates 6.9 F. Hoffmann-La Roche 6.9.1 F. Hoffmann-La Roche Corporation Information 6.9.2 F. Hoffmann-La Roche Description and Business Overview 6.9.3 F. Hoffmann-La Roche Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.9.4 F. Hoffmann-La Roche Tinea Pedis Treatment Product Portfolio 6.9.5 F. Hoffmann-La Roche Recent Developments/Updates 6.10 Sanofi 6.10.1 Sanofi Corporation Information 6.10.2 Sanofi Description and Business Overview 6.10.3 Sanofi Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Sanofi Tinea Pedis Treatment Product Portfolio 6.10.5 Sanofi Recent Developments/Updates 6.11 Teva Pharmaceutical 6.11.1 Teva Pharmaceutical Corporation Information 6.11.2 Teva Pharmaceutical Tinea Pedis Treatment Description and Business Overview 6.11.3 Teva Pharmaceutical Tinea Pedis Treatment Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Teva Pharmaceutical Tinea Pedis Treatment Product Portfolio 6.11.5 Teva Pharmaceutical Recent Developments/Updates 7 Tinea Pedis Treatment Manufacturing Cost Analysis 7.1 Tinea Pedis Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Tinea Pedis Treatment 7.4 Tinea Pedis Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Tinea Pedis Treatment Distributors List 8.3 Tinea Pedis Treatment Customers 9 Tinea Pedis Treatment Market Dynamics 9.1 Tinea Pedis Treatment Industry Trends 9.2 Tinea Pedis Treatment Growth Drivers 9.3 Tinea Pedis Treatment Market Challenges 9.4 Tinea Pedis Treatment Market Restraints 10 Global Market Forecast 10.1 Tinea Pedis Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Tinea Pedis Treatment by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Tinea Pedis Treatment by Type (2022-2027) 10.2 Tinea Pedis Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Tinea Pedis Treatment by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Tinea Pedis Treatment by Application (2022-2027) 10.3 Tinea Pedis Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Tinea Pedis Treatment by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Tinea Pedis Treatment by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Tinea Pedis Treatment Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Tinea Pedis Treatment Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Tinea Pedis Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Tinea Pedis Treatment Covered in This Study Table 5. Global Tinea Pedis Treatment Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Tinea Pedis Treatment Sales Market Share by Manufacturers (2016-2021) Table 7. Global Tinea Pedis Treatment Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Tinea Pedis Treatment Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Tinea Pedis Treatment Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Tinea Pedis Treatment Manufacturing Sites and Area Served Table 11. Manufacturers Tinea Pedis Treatment Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Tinea Pedis Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tinea Pedis Treatment as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Tinea Pedis Treatment Sales by Region (2016-2021) & (K MT) Table 16. Global Tinea Pedis Treatment Sales Market Share by Region (2016-2021) Table 17. Global Tinea Pedis Treatment Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Tinea Pedis Treatment Sales by Country (2016-2021) & (K MT) Table 19. North America Tinea Pedis Treatment Sales Market Share by Country (2016-2021) Table 20. North America Tinea Pedis Treatment Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Tinea Pedis Treatment Revenue Market Share by Country (2016-2021) Table 22. Europe Tinea Pedis Treatment Sales by Country (2016-2021) & (K MT) Table 23. Europe Tinea Pedis Treatment Sales Market Share by Country (2016-2021) Table 24. Europe Tinea Pedis Treatment Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Tinea Pedis Treatment Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Tinea Pedis Treatment Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Tinea Pedis Treatment Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Tinea Pedis Treatment Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Tinea Pedis Treatment Revenue Market Share by Region (2016-2021) Table 30. Latin America Tinea Pedis Treatment Sales by Country (2016-2021) & (K MT) Table 31. Latin America Tinea Pedis Treatment Sales Market Share by Country (2016-2021) Table 32. Latin America Tinea Pedis Treatment Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Tinea Pedis Treatment Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Tinea Pedis Treatment Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Tinea Pedis Treatment Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Tinea Pedis Treatment Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Tinea Pedis Treatment Revenue Market Share by Country (2016-2021) Table 38. Global Tinea Pedis Treatment Sales (K MT) by Type (2016-2021) Table 39. Global Tinea Pedis Treatment Sales Market Share by Type (2016-2021) Table 40. Global Tinea Pedis Treatment Revenue (Million US$) by Type (2016-2021) Table 41. Global Tinea Pedis Treatment Revenue Share by Type (2016-2021) Table 42. Global Tinea Pedis Treatment Price (USD/MT) by Type (2016-2021) Table 43. Global Tinea Pedis Treatment Sales (K MT) by Application (2016-2021) Table 44. Global Tinea Pedis Treatment Sales Market Share by Application (2016-2021) Table 45. Global Tinea Pedis Treatment Revenue (Million US$) by Application (2016-2021) Table 46. Global Tinea Pedis Treatment Revenue Share by Application (2016-2021) Table 47. Global Tinea Pedis Treatment Price (USD/MT) by Application (2016-2021) Table 48. GSK Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. GSK Tinea Pedis Treatment Product Table 52. GSK Recent Developments/Updates Table 53. Exeltis USA Corporation Information Table 54. Exeltis USA Description and Business Overview Table 55. Exeltis USA Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Exeltis USA Tinea Pedis Treatment Product Table 57. Exeltis USA Recent Developments/Updates Table 58. Valeant Corporation Information Table 59. Valeant Description and Business Overview Table 60. Valeant Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Valeant Tinea Pedis Treatment Product Table 62. Valeant Recent Developments/Updates Table 63. Incyte Corporation Information Table 64. Incyte Description and Business Overview Table 65. Incyte Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Incyte Tinea Pedis Treatment Product Table 67. Incyte Recent Developments/Updates Table 68. Celgene Corporation Information Table 69. Celgene Description and Business Overview Table 70. Celgene Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Celgene Tinea Pedis Treatment Product Table 72. Celgene Recent Developments/Updates Table 73. Hisamitsu Pharmaceutical Corporation Information Table 74. Hisamitsu Pharmaceutical Description and Business Overview Table 75. Hisamitsu Pharmaceutical Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Hisamitsu Pharmaceutical Tinea Pedis Treatment Product Table 77. Hisamitsu Pharmaceutical Recent Developments/Updates Table 78. NovaBiotics Corporation Information Table 79. NovaBiotics Description and Business Overview Table 80. NovaBiotics Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. NovaBiotics Tinea Pedis Treatment Product Table 82. NovaBiotics Recent Developments/Updates Table 83. Elorac Corporation Information Table 84. Elorac Description and Business Overview Table 85. Elorac Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Elorac Tinea Pedis Treatment Product Table 87. Elorac Recent Developments/Updates Table 88. F. Hoffmann-La Roche Corporation Information Table 89. F. Hoffmann-La Roche Description and Business Overview Table 90. F. Hoffmann-La Roche Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. F. Hoffmann-La Roche Tinea Pedis Treatment Product Table 92. F. Hoffmann-La Roche Recent Developments/Updates Table 93. Sanofi Corporation Information Table 94. Sanofi Description and Business Overview Table 95. Sanofi Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 96. Sanofi Tinea Pedis Treatment Product Table 97. Sanofi Recent Developments/Updates Table 98. Teva Pharmaceutical Corporation Information Table 99. Teva Pharmaceutical Description and Business Overview Table 100. Teva Pharmaceutical Tinea Pedis Treatment Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 101. Teva Pharmaceutical Tinea Pedis Treatment Product Table 102. Teva Pharmaceutical Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Tinea Pedis Treatment Distributors List Table 106. Tinea Pedis Treatment Customers List Table 107. Tinea Pedis Treatment Market Trends Table 108. Tinea Pedis Treatment Growth Drivers Table 109. Tinea Pedis Treatment Market Challenges Table 110. Tinea Pedis Treatment Market Restraints Table 111. Global Tinea Pedis Treatment Sales Forecast by Type (2022-2027) & (K MT) Table 112. Global Tinea Pedis Treatment Sales Market Share Forecast by Type (2022-2027) Table 113. Global Tinea Pedis Treatment Revenue Forecast by Type (2022-2027) & (US$ Million) Table 114. Global Tinea Pedis Treatment Revenue Market Share Forecast by Type (2022-2027) Table 115. Global Tinea Pedis Treatment Sales Forecast by Application (2022-2027) & (K MT) Table 116. Global Tinea Pedis Treatment Sales Market Share Forecast by Application (2022-2027) Table 117. Global Tinea Pedis Treatment Revenue Forecast by Application (2022-2027) & (US$ Million) Table 118. Global Tinea Pedis Treatment Revenue Market Share Forecast by Application (2022-2027) Table 119. Global Tinea Pedis Treatment Sales Forecast by Region (2022-2027) & (K MT) Table 120. Global Tinea Pedis Treatment Sales Market Share Forecast by Region (2022-2027) Table 121. Global Tinea Pedis Treatment Revenue Forecast by Region (2022-2027) & (US$ Million) Table 122. Global Tinea Pedis Treatment Revenue Market Share Forecast by Region (2022-2027) Table 123. Research Programs/Design for This Report Table 124. Key Data Information from Secondary Sources Table 125. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Tinea Pedis Treatment Figure 2. Global Tinea Pedis Treatment Market Share by Type in 2020 & 2027 Figure 3. Interdigital Product Picture Figure 4. Vesicular Product Picture Figure 5. Global Tinea Pedis Treatment Market Share by Application in 2020 & 2027 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Online Pharmacies Figure 9. Drug Stores Figure 10. Others Figure 11. Global Tinea Pedis Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Tinea Pedis Treatment Market Size 2016-2027 (US$ Million) Figure 13. Global Tinea Pedis Treatment Sales 2016-2027 (K MT) Figure 14. Global Tinea Pedis Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 15. Tinea Pedis Treatment Sales Share by Manufacturers in 2020 Figure 16. Global Tinea Pedis Treatment Revenue Share by Manufacturers in 2020 Figure 17. The Global 5 and 10 Largest Tinea Pedis Treatment Players: Market Share by Revenue in 2020 Figure 18. Tinea Pedis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 19. Global Tinea Pedis Treatment Sales Market Share by Region (2016-2021) Figure 20. Global Tinea Pedis Treatment Sales Market Share by Region in 2020 Figure 21. Global Tinea Pedis Treatment Revenue Market Share by Region (2016-2021) Figure 22. Global Tinea Pedis Treatment Revenue Market Share by Region in 2020 Figure 23. U.S. Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Canada Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Germany Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. France Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. U.K. Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Italy Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Russia Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. China Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Japan Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. South Korea Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. India Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Australia Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Taiwan Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Indonesia Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Thailand Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Malaysia Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Philippines Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Vietnam Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Mexico Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Brazil Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Argentina Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Turkey Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Saudi Arabia Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. U.A.E Tinea Pedis Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Sales Market Share of Tinea Pedis Treatment by Type (2016-2021) Figure 48. Sales Market Share of Tinea Pedis Treatment by Application (2016-2021) Figure 49. Sales Market Share of Tinea Pedis Treatment by Application in 2020 Figure 50. Revenue Share of Tinea Pedis Treatment by Application (2016-2021) Figure 51. Revenue Share of Tinea Pedis Treatment by Application in 2020 Figure 52. Manufacturing Cost Structure of Tinea Pedis Treatment Figure 53. Manufacturing Process Analysis of Tinea Pedis Treatment Figure 54. Tinea Pedis Treatment Industrial Chain Analysis Figure 55. Channels of Distribution Figure 56. Distributors Profiles Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

GSK Exeltis USA Valeant Incyte Celgene Hisamitsu Pharmaceutical NovaBiotics Elorac F. Hoffmann-La Roche Sanofi Teva Pharmaceutical